The use of epidermal growth factor in dermatological practice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, S.H. | - |
dc.contributor.author | Koh, Y.G. | - |
dc.contributor.author | Lee, W.G. | - |
dc.contributor.author | Seok, J. | - |
dc.contributor.author | Park, K.Y. | - |
dc.date.accessioned | 2024-02-01T05:30:37Z | - |
dc.date.available | 2024-02-01T05:30:37Z | - |
dc.date.issued | 2023-08 | - |
dc.identifier.issn | 1742-4801 | - |
dc.identifier.issn | 1742-481X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/71684 | - |
dc.description.abstract | Epidermal growth factor (EGF) is a growth factor that plays a pivotal role in wound healing and maintaining tissue homeostasis by regulating cell survival, proliferation, migration, and differentiation. Exogenous administration of bioidentical human recombinant epidermal growth factor (rhEGF) has been known to promote skin wound healing, although rhEGF is increasingly being used in drug delivery systems and nanotechnology. However, despite considerable attention being focused on the potential clinical applications of rhEGF in several dermatological conditions beyond wound healing, the number of studies still remains relatively low. Herein, we conducted a literature search of PubMed/Medline and Google Scholar databases to retrieve published literature related to rhEGF and summarised the effects of rhEGF in the treatment of various wound types, radiotherapy or chemotherapy-related skin reactions, atopic dermatitis, skin aging, and post-inflammatory hyperpigmentation. © 2022 The Authors. International Wound Journal published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | John Wiley and Sons Inc | - |
dc.title | The use of epidermal growth factor in dermatological practice | - |
dc.type | Article | - |
dc.identifier.doi | 10.1111/iwj.14075 | - |
dc.identifier.bibliographicCitation | International Wound Journal, v.20, no.6, pp 2414 - 2423 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000905796800001 | - |
dc.identifier.scopusid | 2-s2.0-85145304262 | - |
dc.citation.endPage | 2423 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 2414 | - |
dc.citation.title | International Wound Journal | - |
dc.citation.volume | 20 | - |
dc.type.docType | Review | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | cosmetics | - |
dc.subject.keywordAuthor | dermatology | - |
dc.subject.keywordAuthor | epidermal growth factor | - |
dc.subject.keywordAuthor | wound | - |
dc.subject.keywordPlus | DIABETIC FOOT ULCERS | - |
dc.subject.keywordPlus | ATROPHIC ACNE SCARS | - |
dc.subject.keywordPlus | FACTOR EGF SERUM | - |
dc.subject.keywordPlus | TOPICAL APPLICATION | - |
dc.subject.keywordPlus | PROLIFERATION | - |
dc.subject.keywordPlus | SKIN | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | IMPROVEMENT | - |
dc.subject.keywordPlus | PROMOTES | - |
dc.subject.keywordPlus | FIBROBLASTS | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.